$54.27
3.717.34%
al cierre: Aug 21, 5:00 PM EST
$55.42
1.152.12%
After hour: Aug 21, 7:57 PM EST
TG Therapeutics Inc
TGTXNASDAQ
TG Therapeutics Earnings & Forecasts
TG Therapeutics (TGTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TG Therapeutics Guidance
TG Therapeutics (TGTX) publicó su última previsión de agosto 3, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $950M - $950M para el período.
En comparación con la previsión anterior, TG Therapeutics elevado redujo su previsión de ingresos desde un rango anterior de $925M - $925M.
TG Therapeutics ha emitido 10 actualizaciones de orientación entre el enero 14, 2025 y el agosto 3, 2026. During this period, the company raised its outlook 7 times, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.43 | $0.27 | $0.34 | $0.22 |
| Actual | $0.05 | $0.18 | $0.14 | $2.43 |
| Surprise | -88.4% | -33.3% | -58.8% | +1004.6% |
| Revenue | ||||
| Estimate | $228.9M | $200.8M | $191.8M | $151.6M |
| Actual | $240.3M | $204.9M | $192.6M | $161.7M |
| Surprise | +4.98% | +2.03% | +0.42% | +6.69% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.33 | $0.42 | $0.54 | $0.71 |
| Revenue | ||||
| Consensus | $247.1M | $268.9M | — | — |